Merck #00006412102 Gardasil® 9 Human Papillomavirus Vaccine (HPV) For Females 9 to 45 Years of Age / Males 9 through 45 Years of Age 20 mcg - 60 mcg / 0.5 mL Injection Prefilled Syringe Intramuscular GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX) MRKVAC Features GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58 Manufacturer # 00006412102 Brand Gardasil® 9 Manufacturer Merck Country of Origin United States Alternate Manufacturer Number 3422953 Application Human Papillomavirus Vaccine (HPV) Container Type Prefilled Syringe Dosage Form Injection Generic Drug Code 37568 Generic Drug Name Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free NDC Number 00006-4121-02 Product Dating Acceptable Dating: we will ship >= 180 days Storage Requirements Requires Refrigeration Strength 20 mcg - 60 mcg / 0.5 mL Type Intramuscular UNSPSC Code 51201649 User For Females 9 to 45 Years of Age / Males 9 through 45 Years of Age Volume 0.5 mL
Size: 0.5ML
